The estimated Net Worth of Nicolas Soro is at least $79.7 Thousand dollars as of 9 March 2022. Mr. Soro owns over 10,000 units of Sensus Healthcare Inc stock worth over $79,650 and over the last 4 years he sold SRTS stock worth over $0. In addition, he makes $0 as Chief Operating Officer at Sensus Healthcare Inc.
Sign up
Mr. Soro SRTS stock SEC Form 4 insiders trading
Nicolas has made over 1 trades of the Sensus Healthcare Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 10,000 units of SRTS stock worth $55,500 on 9 March 2022.
The largest trade he's ever made was exercising 10,000 units of Sensus Healthcare Inc stock on 9 March 2022 worth over $55,500. On average, Nicolas trades about 3,333 units every 0 days since 2021. As of 9 March 2022 he still owns at least 13,546 units of Sensus Healthcare Inc stock.
You can see the complete history of Mr. Soro stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Nicolas Soro biography
Nicolas Soro serves as Chief Operating Officer of the Company. He previously served as our Director of Regulatory Affairs and Quality Assurance from 2016. In this capacity, he participated in the development of new devices, including assisting us in obtaining multiple 510(k) clearances from the U.S. Food and Drug Administration, including for Sculptura and the software (Sentinel) for treatment planning contained in the SRT-100 Vision and SRT-100 Plus. Prior to joining us, Mr. Soro was Director of Regulatory Affairs and Quality Assurance at DemeTECH Corporation, a world-renowned leader in surgical sutures, mesh and bone wax, from 2011 to 2016. Mr. Soro has a B.S. in applied economics from Florida State University in Tallahassee and has completed coursework in information technology at Florida International University in Miami.
How old is Nicolas Soro?
Nicolas Soro is 35, he's been the Chief Operating Officer of Sensus Healthcare Inc since 2020. There are 13 older and 3 younger executives at Sensus Healthcare Inc. The oldest executive at Sensus Healthcare Inc is John Heinrich, 73, who is the Non-Executive Independent Director.
What's Nicolas Soro's mailing address?
Nicolas's mailing address filed with the SEC is 851 BROKEN SOUND PARKWAY NW STE 215, , BOCA RATON, FL, 33487.
Insiders trading at Sensus Healthcare Inc
Over the last 8 years, insiders at Sensus Healthcare Inc have traded over $8,288,024 worth of Sensus Healthcare Inc stock and bought 88,000 units worth $292,820 . The most active insiders traders include Joseph C Sardano, Stephen Brad Cohen, and Anthony Benedict Petrelli. On average, Sensus Healthcare Inc executives and independent directors trade stock every 29 days with the average trade being worth of $58,482. The most recent stock trade was executed by John Heinrich on 17 May 2024, trading 20,000 units of SRTS stock currently worth $123,400.
What does Sensus Healthcare Inc do?
sensus healthcare, inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancer and keloids. sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (srt), which is a result of over a decade of dedicated research and development activities. sensus has successfully incorporated the srt therapy into its portfolio of treatment devices: srt-100™ and srt-100 vision™. srt technology effectively and safely treats oncological and non-oncological skin conditions. for more information, visit http://www.sensushealthcare.com.
What does Sensus Healthcare Inc's logo look like?
Complete history of Mr. Soro stock trades at Sensus Healthcare Inc
Sensus Healthcare Inc executives and stock owners
Sensus Healthcare Inc executives and other stock owners filed with the SEC include:
-
Stephen Cohen,
Co-Founder, Executive Vice President - Strategic Initiatives and Dermatology Sales -
Joseph C. Sardano,
Co-Founder, Chairman, CEO & Pres -
Joseph Sardano,
Chairman of the Board, President, Chief Executive Officer, Co-Founder -
Stephen Cohen,
Co-Founder & Exec. VP -
Michael J. Sardano,
VP, Gen. Counsel & Corp. Sec. -
Kim Golodetz,
Investor Relations -
Samuel O'Rear,
Non-Executive Independent Director -
William McCall,
Non-Executive Independent Director -
John Heinrich,
Non-Executive Independent Director -
Anthony Petrelli,
Non-Employee Director -
Hoi-Bun Suen,
Vice President of International Sales -
Michael Sardano,
Vice President, General Counsel, Director of Governance and Regulatory -
James Price,
Chief Technology Officer -
Nicolas Soro,
Chief Operating Officer -
Javier Rampolla,
Chief Financial Officer -
Dr. Clay Jefferies Cockerell,
Clinical Director & Member of Medical Advisory Board -
Dr. Mark S. Nestor,
Medical Director & Member of Medical Advisory Board -
Benson Suen,
VP of International Sales -
Yonatan Vainer,
Chief Technology Officer -
Nicolas Soro,
Chief Operating Officer -
Javier Rampolla,
Chief Financial Officer -
Kalman Fishman,
CHIEF TECHNOLOGY OFFICER -
Richard Golin,
EXECUTIVE VICE PRESIDENT -
Arthur Levine,
CHIEF FINANCIAL OFFICER -
Megan Cornish,
-
Magdalena Martinez,
CHIEF OPERATING OFFICER